Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Rituximab, Methotrexate, Procarbazine and Lomustine (R-MPL) for the Treatment of Primary CNS Lymphoma

Eyal Lebel, Neta Goldschmidt, Tali Siegal, MD, Alexander Lossos, MD, Moshe Gatt, MD, Alexander Gural, MD, Adir Shaulov, MD, Revital Saban, MD, David Lavie, MD, Boaz Nachmias, MDPhD

Blood (2020) 136 (Supplement 1): 48–49.

https://doi.org/10.1182/blood-2020-140949

Published: 2020

Journal Articles

Venetoclax Is Safe and Efficacious in Relapsed/ Refractory AML

Chezi Ganzel, MD, Ron Ram, MD, Alexander Gural, MD, Ofir Wolach, MD, Sharon Gino-Moor, MD, Vladimir Vainstein, MD, Boaz Nachmias, MD PhD, Arie Apel, MD, Maya Koren-Michowitz, MD, Oren Pasvolsky, MD, Ronit Yerushalmi, MD, Ivetta Danylesko, Yoseph Cohen, MD, Galit Perets, Yakir Moshe, MD, Miri Zektzer, MD, Shay Yeganeh, MD, Jacob M. Rowe, MB, BS, Yishai Ofran, MD

Blood (2019) 134 (Supplement_1): 5091.

https://doi.org/10.1182/blood-2019-125662

Published: 2019

Journal Articles

A Phase 1 Study Investigating AFM11 in Patients with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: Preliminary Results

Galina Salogub, MD PhD, Jiri Mayer, MD, Frantisek Folber, MD PhD, Sebastian Grosicki, MD PhD, Aleksander B Skotnicki, MD PhD, Anna Prochwicz, MD, Alexander Myasnikov, MD, Alexander Gural, MD, Oliver Schoenborn-Kellenberger, MSc, Charlie Brindley, PhD, Stefan Knackmuss, PhD, Sylvia Schwarz, PhD, Sandra Schmich, Cassandra Choe-Juliak, MD MS, Andras Strassz, MD, Leila Alland, MD, Michael Doubek, MD PhD

Blood (2018) 132 (Supplement 1): 3969.

https://doi.org/10.1182/blood-2018-99-118136

Published: 2018

Journal Articles

Favorable Outcome of Primary Mediastinal Large B-Cell Lymphoma Patients Treated with Sequential R-CHOP/R- ICE Regimen Omitting Radiation

Neta Goldschmidt, MD, Ora B. Paltiel, MDM, MSc, Dina Ben Yehuda, Geffen Kleinstern, Alexander Gural, MD, Diana Libster, MD, David Lavie, MD, Moshe E. Gatt, MD

Blood (2015) 126 (23): 3954.

https://doi.org/10.1182/blood.V126.23.3954.3954

Published: 2015

Journal Articles

Polymorphisms in the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1) and the Multidrug Resistance Gene (MDR1, ABCB1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients

Jacob Vine, medical student, Sara Bar Cohen, PhD, Rosa Ruchlemer, Neta Goldschmidt, MD, Moshe Levin, MD, Diana Libster, MD, Alexander Gural, MD, Moshe E. Gatt, MD, David Lavie, MD, Dina Ben-Yehuda, MD, Deborah Rund, MD

Blood (2012) 120 (21): 1340.

https://doi.org/10.1182/blood.V120.21.1340.1340

Published: 2012

Journal Articles

Polymorphisms in Exons 2 and 7 of the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients,

Jacob Vine, medical student, Sara Bar Cohen, PhD, Rosa Ruchlemer, MD, Neta Goldschmidt, MD, Moshe Levin, MD, Diana Libster, MD, Alexander Gural, MD, Moshe E. Gatt, MD, David Lavie, Dina Ben-Yehuda, MD, Deborah Rund, MD

Blood (2011) 118 (21): 3487.

https://doi.org/10.1182/blood.V118.21.3487.3487

Published: 2011

Journal Articles

The Acetylation of AML1-ETO Is Required for Leukemogenesis.

Lan Wang, PhD, Alexander Gural, MD, Fabiana Perna, MD, Xiaojian Sun, PhD, Xinyang Zhao, PhD, Haiming Xu, PhD, Megan A Hatlen, Gang Huang, Ph.D., Fan Liu, PhD, Hao Xu, MD, Tony Deblasio, Silvia Menendez, Francesca Voza, Robert Roeder, PhD, Stephen Nimer, MD

Blood (2010) 116 (21): 1588.

https://doi.org/10.1182/blood.V116.21.1588.1588

Published: 2010

Journal Articles

The Deletion of NHR1 Region of the AML1-ETO Protein Significantly Decreases Its Ability To Promote Proliferation and Self-Renewal of Early Hematopoietic Cells in Culture.

Alexander Gural, MD, Vladimir Jankovic, MD, Jinsong Zhang, PhD, Robert G. Roeder, PhD, Stephen D. Nimer, MD

Blood (2006) 108 (11): 2550.

https://doi.org/10.1182/blood.V108.11.2550.2550

Published: 2006

Journal Articles

A Pilot Study of Combined Escalated BEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: The Israel Cooperative Lymphoma Group.

Abraham Avigdor, MD, Shlomo Bulvik, MD, Noga Shemtov, MD, Itai Levi, MD, Miriam Berkowicz, MD, Dina Ben-Yehuda, MD, Dorit Blickstein, MD, Neta Goldschmidt, MD, Alexander Gural, MD, Abraham Kornberg, MD, Dianna Libster, MD, Drorit Merkel, MD, Elizabeth Naparstek, MD, Pia Raanani, MD, Batia Roth, MD, Yulia Volchek, MD, Arnon Nagler, MD, Isaac Ben-Bassat, MD, Aaron Polliack, MD

Blood (2004) 104 (11): 4576.

https://doi.org/10.1182/blood.V104.11.4576.4576

Published: 2004

Journal Articles

Application of the Cone and Plate(let) Analyzer as a Point-of-Care Method for Monitoring Anti-Platelet Therapy.

Galia Spectre, MD, Alexander Brill, MD, PhD, Alexander Gural, MD, Boris Shenkman, MD, PhD, Natalia Turetzky, MSc, Naphtali Savion, PhD, David Varon, MD

Blood (2004) 104 (11): 4071.

https://doi.org/10.1182/blood.V104.11.4071.4071

Published: 2004

NARROW

Rituximab, Methotrexate, Procarbazine and Lomustine (R-MPL) for the Treatment of Primary CNS Lymphoma

Venetoclax Is Safe and Efficacious in Relapsed/ Refractory AML

A Phase 1 Study Investigating AFM11 in Patients with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: Preliminary Results

Favorable Outcome of Primary Mediastinal Large B-Cell Lymphoma Patients Treated with Sequential R-CHOP/R- ICE Regimen Omitting Radiation

Polymorphisms in the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1) and the Multidrug Resistance Gene (MDR1, ABCB1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients

Polymorphisms in Exons 2 and 7 of the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients,

The Acetylation of AML1-ETO Is Required for Leukemogenesis.

The Deletion of NHR1 Region of the AML1-ETO Protein Significantly Decreases Its Ability To Promote Proliferation and Self-Renewal of Early Hematopoietic Cells in Culture.

A Pilot Study of Combined Escalated BEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: The Israel Cooperative Lymphoma Group.

Application of the Cone and Plate(let) Analyzer as a Point-of-Care Method for Monitoring Anti-Platelet Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only